• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    64 Biggest Movers From Yesterday

    1/28/22 4:59:13 AM ET
    $ACY
    $AHI
    $ARAY
    $BSFC
    Package Goods/Cosmetics
    Consumer Discretionary
    Medical/Dental Instruments
    Health Care
    Get the next $ACY alert in real time by email

     

    Check out these penny stocks insiders are buying

    Losers

    • ION Geophysical Corporation (NYSE:IO) shares fell 53.6% to settle at $0.51 on Thursday.
    • Epizyme, Inc. (NASDAQ:EPZM) shares dipped 44.2% to close at $1.06 on Thursday after the company priced an underwritten public offering of 56,666,667 shares at $1.50 per share, before underwriting discounts.
    • TG Therapeutics, Inc. (NASDAQ:TGTX) dropped 40.5% to settle at $8.27 on Thursday. TG Therapeutics said the FDA imposed partial clinical hold on select studies of U2 and its components for CLL and NHL.
    • Cyngn Inc. (NASDAQ:CYN) tumbled 35.7% to close at $1.62.
    • PetVivo Holdings, Inc. (NASDAQ:PETV) fell 35% to close at $1.30. PetVivo recently announced distribution of its veterinary medical device, SPRYNG, by Vetcove, Inc.
    • Advanced Human Imaging Limited (NASDAQ:AHI) fell 33.8% to settle at $1.82. Advanced Human Imaging recently signed partnership with Activate Health OÜ.
    • Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) dropped 33.6% to close at $0.6280. Spectrum Pharmaceuticals recently announced a strategic restructuring.
    • LendingClub Corporation (NYSE:LC) dipped 29.2% to settle at $15.92 after the company reported Q4 earnings results and issued Q1 and FY22 sales guidance. Credit Suisse maintained LendingClub with a Neutral and lowered the price target from $34 to $27.
    • Blue Star Foods Corp. (NASDAQ:BSFC) dipped 29% to close at $2.69. Blue Star Foods recently said it will receive $5 million investment from The Lind Partners.
    • Stran & Company, Inc. (NASDAQ:STRN) fell 28.8% to close at $2.28. Stran & Company recently announced definitive agreement to acquire GAP Promo.
    • 1-800-FLOWERS.COM, Inc. (NASDAQ:FLWS) shares declined 28.5% to settle at $15.08 after the company reported worse-than-expected Q2 EPS and sales results. 1-800-Flowers sees FY22 revenue growth of 7% - 9%.
    • Merida Merger Corp. I (NASDAQ:MCMJ) fell 28.4% to close at $7.15.
    • CF Acquisition Corp. V (NASDAQ:SATL) dropped 26.7% to settle at $5.93.
    • ShiftPixy, Inc. (NASDAQ:PIXY) fell 26% to close at $1.28.
    • Volcon, Inc. (NASDAQ:VLCN) fell 25.7% to close at $3.78. Volcon recently filed for offering of 3.5 million shares of common stock.
    • Cue Biopharma, Inc. (NASDAQ:CUE) fell 24.6% to close at $7.99. Cue Biopharma said early data from the Phase 1 combination study of CUE-101 and Merck & Co., supported synergistic activity, with two of the four patients treated in dose escalation in two cohosts showing partial responses.
    • AeroCentury Corp. (NYSE:ACY) dipped 23.3% to settle at $6.14.
    • Vistas Media Acquisition Company Inc. (NASDAQ:VMAC) fell 22.6% to close at $10.31. Vistas Media Acquisition Company shareholders recently approved business combination with Anghami.
    • Teradyne, Inc. (NASDAQ:TER) fell 22.4% to close at $111.24 after the company issued Q1 EPS and sales guidance below estimates.
    • Yoshitsu Co., Ltd (NASDAQ:TKLF) dropped 21.8% to close at $2.55.
    • Weidai Ltd. (NYSE:WEI) fell 20.9% to close at $1.85.
    • GWG Holdings, Inc. (NASDAQ:GWGH) dropped 20.5% to close at $2.95.
    • IsoPlexis Corporation (NASDAQ:ISO) fell 19.7% to close at $6.27. SVB Leerink maintained IsoPlexis with an Outperform and lowered the price target from $20 to $15.
    • Ebang International Holdings Inc. (NASDAQ:EBON) fell 19.3% to close at $0.8794 after jumping 35% on Wednesday.
    • Guardforce AI Co., Limited (NASDAQ:GFAI) dipped 19.1% to settle at $0.7199. Guardforce AI recently announced pricing of a $10.3 million offering.
    • Eros STX Global Corporation (NYSE:ESGC) fell 18.2% to close at $0.3007.
    • Ivanhoe Capital Acquisition Corp. (NYSE:IVAN) fell 17.9% to close at $8.19.
    • Unifi, Inc. (NYSE:UFI) dropped 17.6% to close at $18.50 following Q2 earnings.
    • FGI Industries Ltd. (NASDAQ:FGI) fell 15.7% to settle at $3.16. The company recently priced its IPO at $6 per share.
    • Accuray Incorporated (NASDAQ:ARAY) fell 15.2% to close at $3.45 following Q2 results.
    • Watts Water Technologies, Inc. (NYSE:WTS) fell 13% to close at $147.88. Watts Water Technologies will replace Sterling Bancorp/DE in the S&P MidCap 400.
    • Tesla, Inc. (NASDAQ:TSLA) dipped 11.6% to close at $829.10. Tesla reported better-than-expected earnings and sales results for its fourth quarter. The company produced 305,840 vehicles in the fourth quarter, up 70% year-over-year. A total of 308,650 vehicles were delivered in the fourth quarter, up 71% year-over-year.
    • Zymeworks Inc. (NASDAQ:ZYME) shares fell 10.9% to close at $8.30 after the company reported pricing of $100.0 million public offering.
    • CITIC Capital Acquisition Corp. (NYSE:CCAC) fell 10% to close at $8.92.
    • LG Display Co., Ltd. (NYSE:LPL) slipped 8.3% to settle at $8.07. LG Display recently reported fourth-quarter FY21 revenue growth of 18% year-on-year to KRW 8.81 trillion.
    • Haemonetics Corporation (NYSE:HAE) dropped 7.7% to close at $43.77. Needham downgraded Haemonetics from Buy to Hold.
    • SAP SE (NYSE:SAP) fell 7.5% to close at $122.38. SAP reported fourth-quarter FY21 revenue growth of 3% year-on-year to €7.98 billion at constant currencies and announced plans to acquire a majority stake of Taulia, a leading provider of working capital management solutions.
    • Intel Corporation (NASDAQ:INTC) fell 7% to close at $48.05 after the company issued Q1 EPS guidance below estimates.

    Also check out insider selling in big stocks

    Get the next $ACY alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ACY
    $AHI
    $ARAY
    $BSFC

    CompanyDatePrice TargetRatingAnalyst
    Intel Corporation
    $INTC
    4/24/2026$60.00 → $80.00Hold
    Jefferies
    Intel Corporation
    $INTC
    4/24/2026$48.00 → $56.00Underperform
    BofA Securities
    Intel Corporation
    $INTC
    4/24/2026$50.00 → $75.00Neutral
    Robert W. Baird
    Intel Corporation
    $INTC
    4/24/2026$35.00 → $45.00Underweight
    Analyst
    Intel Corporation
    $INTC
    4/24/2026$70.00 → $110.00Overweight
    KeyBanc Capital Markets
    Intel Corporation
    $INTC
    4/24/2026$65.00 → $75.00Hold
    Stifel
    Intel Corporation
    $INTC
    4/24/2026$76.00 → $105.00Buy
    The Benchmark Company
    Intel Corporation
    $INTC
    4/24/2026$48.00 → $80.00Sector Perform
    RBC Capital Mkts
    More analyst ratings

    $ACY
    $AHI
    $ARAY
    $BSFC
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Jefferies reiterated coverage on Intel with a new price target

    Jefferies reiterated coverage of Intel with a rating of Hold and set a new price target of $80.00 from $60.00 previously

    4/24/26 10:40:55 AM ET
    $INTC
    Semiconductors
    Technology

    BofA Securities reiterated coverage on Intel with a new price target

    BofA Securities reiterated coverage of Intel with a rating of Underperform and set a new price target of $56.00 from $48.00 previously

    4/24/26 10:40:34 AM ET
    $INTC
    Semiconductors
    Technology

    Robert W. Baird reiterated coverage on Intel with a new price target

    Robert W. Baird reiterated coverage of Intel with a rating of Neutral and set a new price target of $75.00 from $50.00 previously

    4/24/26 10:40:23 AM ET
    $INTC
    Semiconductors
    Technology

    $ACY
    $AHI
    $ARAY
    $BSFC
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    New Study Highlights Safety and Efficacy Profile of Haemonetics' VASCADE MVP® XL in Large-Bore Venous Access Closure Procedures

    BOSTON, April 24, 2026 /PRNewswire/ -- Haemonetics Corporation (NYSE:HAE), a global medical technology company focused on delivering innovative solutions designed to improve patient outcomes, today announced the publication of a new study comparing its VASCADE MVP® XL vascular closure system with the VASCADE MVP® venous vascular closure system in the context of large‐bore venous access closure procedures. This study, "VASCADE MVP-XL Versus VASCADE MVP for Large-Bore Venous Access-Site Closure in Electrophysiology Procedures: A Single-Center Experience on Efficacy and Complications," was published earlier this week in the Journal of Cardiovascular Electrophysiology.The retrospective, non‐rand

    4/24/26 6:20:00 AM ET
    $HAE
    Medical/Dental Instruments
    Health Care

    SAP Quarterly Statement Q1 2026

    WALLDORF, Germany, April 23, 2026 /PRNewswire/ -- SAP SE (NYSE:SAP) announced today its financial results for the first quarter ended March 31, 2026. Current cloud backlog of €21.9 billion, up 20% and up 25% at constant currenciesCloud revenue up 19% and up 27% at constant currenciesCloud ERP Suite revenue up 23% and up 30% at constant currenciesTotal revenue up 6% and up 12% at constant currenciesIFRS operating profit up 17%, non-IFRS operating profit up 17% and up 24% at constant currenciesChristian Klein, CEO:We had a strong start to the year, with Current Cloud Backlog growi

    4/23/26 4:18:00 PM ET
    $SAP
    Computer Software: Prepackaged Software
    Technology

    Intel Reports First-Quarter 2026 Financial Results

    News Summary First-quarter revenue was $13.6 billion, up 7% year-over-year (YoY). First-quarter earnings (loss) per share (EPS) attributable to Intel was $(0.73); non-GAAP EPS attributable to Intel was $0.29. Forecasting second-quarter 2026 revenue of $13.8 billion to $14.8 billion; expecting second-quarter EPS attributable to Intel of $0.08 and non-GAAP EPS attributable to Intel of $0.20. Intel Corporation today reported first-quarter 2026 financial results. "The next wave of AI will bring intelligence closer to the end user, moving from foundational models to inference to agentic. This shift is significantly increasing the need for Intel's CPUs and wafer and advanced packagi

    4/23/26 4:01:00 PM ET
    $INTC
    Semiconductors
    Technology

    $ACY
    $AHI
    $ARAY
    $BSFC
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    CEO Musk Elon returned 96,000,000 shares to the company, decreasing direct ownership by 18% to 423,743,904 units (SEC Form 4)

    4 - Tesla, Inc. (0001318605) (Issuer)

    4/23/26 4:05:10 PM ET
    $TSLA
    Auto Manufacturing
    Industrials

    SEC Form 3 filed by new insider Kharsansky Alan

    3 - Satellogic Inc. (0001874315) (Issuer)

    4/22/26 5:35:38 PM ET
    $SATL
    Radio And Television Broadcasting And Communications Equipment
    Technology

    SEC Form 4 filed by Fund 1 Investments, Llc

    4 - 1 800 FLOWERS COM INC (0001084869) (Issuer)

    4/22/26 5:26:57 PM ET
    $FLWS
    Other Specialty Stores
    Consumer Discretionary

    $ACY
    $AHI
    $ARAY
    $BSFC
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Large owner A.L. Sarroff Fund, Llc bought 1,250,000 shares (SEC Form 4)

    4 - PetVivo Holdings, Inc. (0001512922) (Issuer)

    3/13/26 5:10:25 PM ET
    $PETV
    Medical/Dental Instruments
    Health Care

    Director Mayer Steven F bought $30,878 worth of shares (54,875 units at $0.56), increasing direct ownership by 4% to 1,545,620 units (SEC Form 4)

    4 - ACCURAY INC (0001138723) (Issuer)

    2/23/26 4:10:08 PM ET
    $ARAY
    Medical/Dental Instruments
    Health Care

    Director Mayer Steven F bought $103,797 worth of shares (195,125 units at $0.53), increasing direct ownership by 15% to 1,490,745 units (SEC Form 4)

    4 - ACCURAY INC (0001138723) (Issuer)

    2/20/26 4:10:06 PM ET
    $ARAY
    Medical/Dental Instruments
    Health Care

    $ACY
    $AHI
    $ARAY
    $BSFC
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for BRIUMVI issued to TG THERAPEUTICS, INC

    Submission status for TG THERAPEUTICS, INC's drug BRIUMVI (SUPPL-11) with active ingredient UBLITUXIMAB-XIIY has changed to 'Approval' on 10/30/2024. Application Category: BLA, Application Number: 761238, Application Classification:

    10/31/24 4:38:40 AM ET
    $TGTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for TAZVERIK issued to EPIZYME INC

    Submission status for EPIZYME INC's drug TAZVERIK (SUPPL-5) with active ingredient TAZEMETOSTAT HYDROBROMIDE has changed to 'Approval' on 08/13/2024. Application Category: NDA, Application Number: 211723, Application Classification: Labeling

    8/14/24 4:43:30 AM ET
    $EPZM
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for TAZVERIK issued to EPIZYME INC

    Submission status for EPIZYME INC's drug TAZVERIK (SUPPL-4) with active ingredient TAZEMETOSTAT HYDROBROMIDE has changed to 'Approval' on 11/16/2023. Application Category: NDA, Application Number: 211723, Application Classification: Labeling

    11/17/23 4:37:35 AM ET
    $EPZM
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ACY
    $AHI
    $ARAY
    $BSFC
    SEC Filings

    View All

    SEC Form SCHEDULE 13G filed by LendingClub Corporation

    SCHEDULE 13G - LendingClub Corp (0001409970) (Subject)

    4/24/26 12:34:19 PM ET
    $LC
    Finance: Consumer Services
    Finance

    SEC Form SCHEDULE 13G filed by LendingClub Corporation

    SCHEDULE 13G - LendingClub Corp (0001409970) (Subject)

    4/24/26 12:30:22 PM ET
    $LC
    Finance: Consumer Services
    Finance

    SEC Form 10-Q filed by Intel Corporation

    10-Q - INTEL CORP (0000050863) (Filer)

    4/23/26 6:49:27 PM ET
    $INTC
    Semiconductors
    Technology

    $ACY
    $AHI
    $ARAY
    $BSFC
    Financials

    Live finance-specific insights

    View All

    SAP Quarterly Statement Q1 2026

    WALLDORF, Germany, April 23, 2026 /PRNewswire/ -- SAP SE (NYSE:SAP) announced today its financial results for the first quarter ended March 31, 2026. Current cloud backlog of €21.9 billion, up 20% and up 25% at constant currenciesCloud revenue up 19% and up 27% at constant currenciesCloud ERP Suite revenue up 23% and up 30% at constant currenciesTotal revenue up 6% and up 12% at constant currenciesIFRS operating profit up 17%, non-IFRS operating profit up 17% and up 24% at constant currenciesChristian Klein, CEO:We had a strong start to the year, with Current Cloud Backlog growi

    4/23/26 4:18:00 PM ET
    $SAP
    Computer Software: Prepackaged Software
    Technology

    Mobileye Releases First Quarter 2026 Results, Updates Full-Year Outlook, and Announces a $250 Million Share Repurchase Program

    Revenue of $558 million in the first quarter increased 27% year over year compared to Q1 2025. We are raising the midpoint of our full-year 2026 revenue guidance by 2% to reflect better-than-expected demand in the first quarter. Diluted EPS (GAAP) was $(4.68) and Adjusted Diluted EPS (Non-GAAP) was $0.12 in the first quarter. GAAP Operating Loss was impacted by a non-cash goodwill impairment of $3,788 million related to the goodwill asset on Mobileye's balance sheet resulting from Intel's acquisition of Mobileye in 2017. Generated $75 million of operating cash flow in the first quarter of 2026. The acquisition of Mentee Robotics Ltd. ("Mentee Robotics") closed in early February, r

    4/23/26 7:15:00 AM ET
    $INTC
    $MBLY
    Semiconductors
    Technology
    Computer Software: Prepackaged Software

    Mobileye Announces Share Repurchase Program of Up to $250 Million

    Mobileye Global Inc. (NASDAQ:MBLY) today announced its Board of Directors has authorized a program to repurchase up to $250 million of Mobileye's outstanding Class A common stock (the "Repurchase Program"). The share repurchase program demonstrates both the leadership team and Board of Directors' confidence in the Company's current products as well as its position as a leader in the development and deployment of advanced driver assistance systems, autonomous driving solutions, and complex physical AI systems at scale. The Repurchase Program is intended to partially offset dilution associated with share-based compensation and shares issued in connection with the Mentee Robotics acquisition

    4/23/26 6:15:00 AM ET
    $INTC
    $MBLY
    Semiconductors
    Technology
    Computer Software: Prepackaged Software

    $ACY
    $AHI
    $ARAY
    $BSFC
    Leadership Updates

    Live Leadership Updates

    View All

    The NHL, SAP and HEC Montréal unveil a free game powered by real hockey data - Developing Students' Analytical Skills

    MONTREAL, April 15, 2026 /CNW/ - To help prepare students from all disciplines for the analytical skills increasingly sought after in the job market, the National Hockey League (NHL), SAP and HEC Montréal are unveiling a free game powered by real professional hockey data: "The Hockey Analyst." Developed by the ERPsim Lab team at HEC Montréal under the direction of Professor Pierre–Majorique Léger, the game is designed to equip higher–education teaching staff around the world. It offers students an immersive and intuitive learning experience that helps them naturally acquire skills expected in today's professional environments, such as data interpretation and visualization, decision–making, a

    4/15/26 6:03:00 AM ET
    $SAP
    Computer Software: Prepackaged Software
    Technology

    Zymeworks Announces Additional Leadership Appointments to Advance Next Phase of Growth

    • Adam Schayowitz, Ph.D., MBA appointed as Head of R&D• Scott Platshon appointed as Chief Business Officer  VANCOUVER, British Columbia, April 09, 2026 (GLOBE NEWSWIRE) -- Zymeworks Inc. (NASDAQ:ZYME), a biotechnology company managing a portfolio of licensed healthcare assets, while developing a diverse pipeline of novel, multifunctional biotherapeutics, today announced the full-time appointments of Dr. Adam Schayowitz and Mr. Scott Platshon as of April 9, 2026, from their previously interim roles. Both Dr. Schayowitz and Mr. Platshon will report directly to Kenneth Galbraith, Chair and Chief Executive Officer of Zymeworks. "These appointments come at a pivotal time for Zymeworks as we e

    4/9/26 6:00:00 AM ET
    $ZYME
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Accuray Appoints Paul Miele as Senior Vice President and Chief Commercial Officer

    MADISON, Wis., April 6, 2026 /PRNewswire/ -- Accuray Incorporated (NASDAQ:ARAY), a leading provider of radiation therapy systems for cancer treatment, today announced the appointment of Paul Miele as Senior Vice President and Chief Commercial Officer, effective April 6, 2026. Miele will join Accuray's executive leadership team and lead the company's global commercial organization as Accuray continues to advance its transformation and strengthen execution across its portfolio. "Paul brings deep global commercial leadership experience and a strong track record of driving transform

    4/6/26 9:00:00 AM ET
    $ARAY
    Medical/Dental Instruments
    Health Care

    $ACY
    $AHI
    $ARAY
    $BSFC
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Satellogic Inc.

    SC 13D/A - Satellogic Inc. (0001874315) (Subject)

    11/27/24 4:30:03 PM ET
    $SATL
    Radio And Television Broadcasting And Communications Equipment
    Technology

    Amendment: SEC Form SC 13D/A filed by Satellogic Inc.

    SC 13D/A - Satellogic Inc. (0001874315) (Subject)

    11/21/24 8:39:01 PM ET
    $SATL
    Radio And Television Broadcasting And Communications Equipment
    Technology

    Amendment: SEC Form SC 13G/A filed by PetVivo Holdings Inc.

    SC 13G/A - PetVivo Holdings, Inc. (0001512922) (Subject)

    11/19/24 3:38:53 PM ET
    $PETV
    Medical/Dental Instruments
    Health Care